Zhejiang Starry Pharm Co Ltd (603520) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Based on the latest financial reports, Zhejiang Starry Pharm Co Ltd (603520) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.76 Million ≈ $1.43 Million USD) by net assets (CN¥2.61 Billion ≈ $381.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Starry Pharm Co Ltd (603520) defensive interval to measure how many days the company can operate on defensive assets alone.

Zhejiang Starry Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Zhejiang Starry Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Starry Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Starry Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Rongcheer Industrial Technology (Suzhou) Co. Ltd. A SHE:301360	N/A
SGSG Science&technology Co Ltd Zhuhai SHE:300561	0.008x
Onterris NYSE:ONT	-0.026x
Gloria Material Technology TWO:5009	0.023x
Xiamen Yanjan New Material Co Ltd SHE:300658	0.069x
Shandong Sunway Petrochemical Engineering Co Ltd SHE:002469	0.036x
Qingdao Greensum Ecology Co. Ltd. SHE:300948	N/A
Stylam Industries Limited NSE:STYLAMIND	0.104x

Annual Cash Flow Conversion Efficiency for Zhejiang Starry Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Starry Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 603520 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.56 Billion ≈ $375.23 Million	CN¥3.67 Million ≈ $536.56K	0.001x	-98.05%
2024-12-31	CN¥2.63 Billion ≈ $385.50 Million	CN¥193.50 Million ≈ $28.32 Million	0.073x	+180.09%
2023-12-31	CN¥1.76 Billion ≈ $257.38 Million	CN¥46.13 Million ≈ $6.75 Million	0.026x	+159.27%
2022-12-31	CN¥1.77 Billion ≈ $259.18 Million	CN¥-78.37 Million ≈ $-11.47 Million	-0.044x	-119.26%
2021-12-31	CN¥2.21 Billion ≈ $324.06 Million	CN¥508.84 Million ≈ $74.46 Million	0.230x	+145.57%
2020-12-31	CN¥1.86 Billion ≈ $272.87 Million	CN¥174.48 Million ≈ $25.53 Million	0.094x	-60.99%
2019-12-31	CN¥1.03 Billion ≈ $150.53 Million	CN¥246.77 Million ≈ $36.11 Million	0.240x	+15.41%
2018-12-31	CN¥922.96 Million ≈ $135.06 Million	CN¥191.84 Million ≈ $28.07 Million	0.208x	+901.60%
2017-12-31	CN¥872.44 Million ≈ $127.67 Million	CN¥18.10 Million ≈ $2.65 Million	0.021x	+123.47%
2016-12-31	CN¥827.01 Million ≈ $121.02 Million	CN¥7.68 Million ≈ $1.12 Million	0.009x	-95.52%
2015-12-31	CN¥457.70 Million ≈ $66.98 Million	CN¥94.88 Million ≈ $13.88 Million	0.207x	-37.79%
2014-12-31	CN¥432.13 Million ≈ $63.23 Million	CN¥144.00 Million ≈ $21.07 Million	0.333x	+71.57%
2013-12-31	CN¥386.11 Million ≈ $56.50 Million	CN¥74.99 Million ≈ $10.97 Million	0.194x	-36.70%
2012-12-31	CN¥336.81 Million ≈ $49.29 Million	CN¥103.34 Million ≈ $15.12 Million	0.307x	+325.46%
2011-12-31	CN¥301.81 Million ≈ $44.16 Million	CN¥-41.07 Million ≈ $-6.01 Million	-0.136x	--

About Zhejiang Starry Pharm Co Ltd

SHG:603520 China Drug Manufacturers - Specialty & Generic

Market Cap

$610.74 Million

CN¥4.17 Billion CNY

Market Cap Rank

#11384 Global

#3248 in China

Share Price

CN¥9.52

Change (1 day)

+1.28%

52-Week Range

CN¥9.14 - CN¥13.75

All Time High

CN¥651.92